Funding Details
- Awarder
- Inbox
- Date Award
- May 18, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- Montara Therapeutics is a preclinical-stage biopharmaceutical company pursuing novel approaches to develop safer and more efficacious treatments for neurological diseases. Montara's BrainOnly™ platform enables brain-specific pharmacology by leveraging existing and novel chemical warheads, restricting deleterious on-target / off-tissue peripheral activity.
- Market
- CNS diseases
- Location
-
San Francisco,
California,
USA
- Coinvestors
- SV Health Investors' Dementia Discovery Fund, Two Bear Capital, Dolby Family Ventures, KdT Ventures, BEVC
Links